A phase I proof-of-concept trial comparing the bioavailability and tolerability of fenofibrate formulated with mesoporous silica and a marketed micronised formulation in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2012
At a glance
- Drugs Fenofibrate (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- 23 Mar 2012 New trial record
- 20 Mar 2012 Status changed to completed based on a Formac Pharmaceuticals media release.
- 20 Mar 2012 Results reported in a Formac Pharmaceuticals media release.